Glaucoma UK launches new research grant programme to support innovative glaucoma research

Glaucoma UK is thrilled to announce the launch of its reshaped research programme for 2025 to support innovative research to improve the understanding, treatment, and care of glaucoma. The charity is committed to funding the most promising researchers and proposals...

Ciliatech appoints world-class panel of eyecare specialists to newly created KOL advisory board

Ciliatech will leverage ophthalmic expertise of seven-member advisory board to bring to market Intercil® Uveal Spacer, a novel glaucoma implant offering unique benefits to eye surgeons and patients across the globe Ciliatech, an innovative medtech company focusing on the treatment...

New President and President-elect of the UK and Éire Glaucoma Society (UKEGS) announced

Glaucoma UK has announced the appointments of the new President and President-elect for the UK and Éire Glaucoma Society (UKEGS). Taking over from Ms Nishani Amerasinghe, the 2025 President is Dr Andrew Tatham who is a consultant at Princess Alexandra...

Report: UKEGS 2024

It was an incredible experience heading down to UKEGS 2024 earlier this month in Southampton. The entire Glaucoma UK team, along with the UKEGS overseeing panel Nishani Amerasinghe, Andrew Tatham, Professir Anthony King and Professor Gus Gazzard, took great care...

From dry eyes to glaucoma: How the menopause impacts your eyes and what to do about it, according to an optician

Menopause, much like entering puberty, comes with hormonal disruptions that change a woman's body and behaviour. Some of the first visible side effects are hot flushes, weight gain, and acne, accompanied by behavioural symptoms like mood swings, insomnia, and brain...

The Worshipful Company of Spectacle Makers rewards early career research

The Worshipful Company of Spectacle Makers (WCSM) this week announced the winners of its annual bronze medal award competitions for vision research. Both the winning submissions demonstrated models for earlier diagnosis of significant eye disease and have the capacity to...

Vision for the future: Changes to Glaucoma UK’s research programme in 2025

Glaucoma UK is excited to announce a new, reshaped Research Grants Programme for 2025. Set to open in January, this programme aims to support innovative research to improve the understanding, treatment, and care of glaucoma. Alongside opportunities for researchers at...

Glaucoma UK and the Royal College of Ophthalmologists announce the 2024 research award winners

Glaucoma UK and the Royal College of Ophthalmologists are delighted to announce the winners of the 2024 Glaucoma UK/RCOphth Research Award. As a result of the high quality of applications received, the judging panel have awarded two projects, worth nearly...

Preview: UKEGS 2024

Pretty soon it’s going to be the 9th of October, and a quick Wikipedia search will tell you of how this day in history has seen the founding of the Kingdom of Valencia, the initial whispers of the Prague Astronomical...

CHEC expands transformative MIGS service

CHEC, a community healthcare provider delivering specialist ophthalmology services on behalf of the NHS, has announced the expansion of its minimally invasive glaucoma surgery (MIGS) service. MIGS is an innovative approach combining glaucoma treatment with cataract surgery, utilising advanced techniques...

MicroPulse Transscleral Laser Therapy: A Prospective UK Study

Register now to participate. Eagerly anticipated and now underway – a landmark UK medical research study on MicroPulse® Transscleral Laser Therapy (MPTLT) for the treatment of glaucoma using Iridex’ Cyclo G6® Laser and the MicroPulse P3® Delivery Device. A NICE-compliant...

Biomarkers reveal how patients with glaucoma may respond to treatment

Markers in the blood that predict whether glaucoma patients are at higher risk of continued loss of vision following conventional treatment have been identified by researchers at UCL and Moorfields Eye Hospital.

  • 1 (current)
  • 2
  • 3